Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Biosearch Appoints Uniscience as Brazilian Distributor

Published: Tuesday, May 22, 2012
Last Updated: Tuesday, May 22, 2012
Bookmark and Share
Uniscience to sell, market, and support Biosearch’s inventoried and custom products in the country of Brazil.

Biosearch Technologies, Inc. has announced that Uniscience is the new distributor authorized to sell, market, and support Biosearch’s inventoried and custom products in the country of Brazil.

A few product lines in which Uniscience will focus their sales efforts include custom qPCR probes and primers, custom oligonucleotides, and Stellaris RNA FISH probes.

Uniscience has served the Brazilian market for over 26 years providing superior service, support, and technical expertise to the biotechnology, diagnostic and molecular biology markets.

“We are delighted with this new partnership and are very glad to introduce the Biosearch product line into the Brazilian market,” says Sergio Joelsons, CEO & President of Uniscience.

“Biosearch is excited to build on its expanding global distribution network and is pleased to partner with Uniscience to introduce Biosearch products to Brazilian scientists. Uniscience’s technical sales and support teams in Brazil will be able to build on Biosearch’s established reputation for providing custom oligonucleotides of exceptional quality and a level of customer service unmatched in the industry,” says Harrison Ransom, Director of Marketing and Sales at Biosearch Technologies.

Establishing Uniscience as an authorized distributor in Brazil is part of Biosearch’s strategic global expansion in making BHQ® probes, Stellaris RNA FISH, and sophisticated custom oligonucleotide synthesis options more readily available worldwide.

Uniscience is now part of Biosearch’s growing network of over 30 international distributors.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biosearch Technologies Licenses RNA FISH-based Inventions from UMDNJ
Stellaris® Probe alliance - NextGen Gene Expression™, SNP FISH™, and iceFISH™ in research and clinical applications.
Tuesday, March 19, 2013
Biosearch Acquires Worldwide Rights to Non-FRET Probes Patents
Company has acquired rights from UMDNJ to United States Patent 6,150,097.
Thursday, August 23, 2012
Biosearch and Seegene Finalize Oligonucleotide Supply and BHQ®, CAL Fluor® and Quasar® Licensing Agreements
Biosearch will manufacture both research and IVD grade oligonucleotides for Seegene.
Thursday, October 21, 2010
Biosearch Technologies Awarded Second Phase II Army SBIR Grant
The $750,000+ Phase II grant will continue the design and development of accurate assays for pathogens of military importance.
Thursday, October 14, 2010
Biosearch Technologies Awarded Phase II Army SBIR Grant
The $800,000+ Phase II grant is aimed to back the design and development of rapid and accurate assays for pathogens of military importance.
Thursday, September 23, 2010
Biosearch Technologies Expands Licensing of QIAGEN Scorpions®
According to the agreement, the company obtains rights to manufacture primer assays for research, applied markets and infectious diseases.
Friday, August 13, 2010
Biosearch Technologies Selected for SBIR Grants Issued by the DoD for Disease Detection
Both the Phase I grants aim to develop sensitive analyte specific reagents for a total of twelve pathogens of military importance.
Friday, October 09, 2009
Biosearch Technologies Provides Probe and Primer Reagents for Swine Influenza A/H1n1 Viral Strains
The Company responds to the swine influenza pandemic by offering the rapid custom synthesis of all research use only oligonucleotide probes and primers.
Monday, May 18, 2009
CAL FluorR Patent Issued to Biosearch Technologies
Company has been awarded U.S. Patent describing the CAL Fluor® series of fluorescent dyes for modifying synthetic DNA to enhance its detectability.
Wednesday, April 02, 2008
Scientific News
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
Detecting When Hormone Treatment for Breast Cancer Stops Working
Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further treatment.
Packaging and Unpacking of the Genome
New research improves understanding of the importance of histone replacement.
New Way to Find DNA Damage
University of Utah chemists devised a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.
How Different Treatments for Crohn's Effect the Microbiome
Different treatments for Crohn's disease in children affects their gut microbes in distinct ways, which has implications for future development of microbial-targeted therapies for these patients, according to a study led by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Charting the 'Genomic Biography' of Leukemia
A new study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard offers a glimpse of the wealth of information that can be gleaned by combing the genome of a large collection of leukemia tissue samples.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos